FACE: the barefaced facts of AI potency

The use of third-generation aromatase inhibitors (AIs), such as anastrozole and letrozole, as initial adjuvant hormonal therapy in postmenopausal women (PMW) with hormone receptor-positive (HR+) breast cancer offers a significant benefit over tamoxifen for reducing recurrence risk. Clinical studies,...

Descripción completa

Detalles Bibliográficos
Autor principal: Monnier, Alain
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004571/
https://www.ncbi.nlm.nih.gov/pubmed/21188118
http://dx.doi.org/10.2147/CMR.S13511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004571/
https://www.ncbi.nlm.nih.gov/pubmed/21188118
http://dx.doi.org/10.2147/CMR.S13511

Ejemplares similares